American Century Companies Inc Intellia Therapeutics, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 438,436 shares of NTLA stock, worth $5.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

438,436

Previous 330,514 32.65%

Holding current value

$5.87 Million

Previous $7.4 Million 21.81%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$19.72 - $27.36 $2.13 Million - $2.95 Million	107,922 Added 32.65%	438,436 $9.01 Million
Q2 2024 Aug 07, 2024	BUY	$20.02 - $27.22 $1.27 Million - $1.73 Million	63,550 Added 23.8%	330,514 $7.4 Million
Q1 2024 May 14, 2024	BUY	$23.82 - $32.8 $439,121 - $604,668	18,435 Added 7.42%	266,964 $7.34 Million
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $5.76 Million - $8.04 Million	248,529 New	248,529 $7.58 Million
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $469,968 - $680,428	14,863 Added 5.89%	267,213 $8.45 Million
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $3.39 Million - $4.52 Million	-98,145 Reduced 28.0%	252,350 $10.3 Million
Q1 2023 May 11, 2023	BUY	$33.3 - $44.82 $633,066 - $852,073	19,011 Added 5.74%	350,495 $13.1 Million
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $2.1 Million - $3.97 Million	63,361 Added 23.63%	331,484 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $3.02 Million - $4.02 Million	56,001 Added 26.4%	268,123 $15 Million
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $5.33 Million - $10.6 Million	138,524 Added 188.22%	212,122 $11 Million
Q1 2022 May 11, 2022	SELL	$58.27 - $118.99 $56,230 - $114,825	-965 Reduced 1.29%	73,598 $5.35 Million
Q4 2021 Feb 07, 2022	BUY	$100.76 - $138.36 $288,576 - $396,263	2,864 Added 3.99%	74,563 $8.82 Million
Q3 2021 Nov 10, 2021	BUY	$132.37 - $176.78 $1.34 Million - $1.79 Million	10,107 Added 16.41%	71,699 $9.62 Million
Q2 2021 Aug 05, 2021	BUY	$60.88 - $161.91 $3.75 Million - $9.97 Million	61,592 New	61,592 $9.97 Million

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.02B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Intellia Therapeutics, Inc. Transaction History